Accurate lists of current clinical trials are maintained by a number of national authorities. The information is intended for people looking for trials to participate in. However, it may also be useful for those interested in the research that is currently underway.
The databases listed below provide information on current clinical trials (Project title, Description of project, Location, Start date, End date). It is worth searching more than one of these databases as none appear comprehensive:
We have an ongoing list of updates to trials and new trials here:
-
Influenza Associated Aspergillosis In-depth Investigation20 November 2018
Conditions: Influenza With Pneumonia; Invasive Pulmonary Aspergillosis
Intervention:
Sponsor: Universitaire Ziekenhuizen Leuven
Recruiting -
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels6 November 2018
Conditions: Aspergillosis Invasive; Fungal Infection
Interventions: Genetic: Voriconazole genotype-specific dosing; Drug: Standard of Care
Sponsor: University Health Network, Toronto
Recruiting -
Study to Evaluate the Safety and Efficacy of the Combination Therapy of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis14 September 2018
Condition: Invasive Pulmonary Aspergillosis
Interventions: Drug: SCY-078; Drug: Voriconazole; Other: Oral Placebo Tablets
Sponsor: Scynexis, Inc.
Recruiting -
Chronic Pulmonary Aspergillosis and Ambisome Aerosol With Itraconazole3 September 2018
Condition: Chronic Pulmonary Aspergillosis
Interventions: Drug: inhaled Ambisome®; Drug: inhaled placebo; Drug: Itraconazole
Sponsor: Poitiers University Hospital
Recruiting -
Cytokine Profile of Allergic Bronchopulmonary Aspergillosis22 August 2018
Condition: ABPA
Intervention:
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Recruiting -
Invasive Pulmonary Aspergillosis Complicating Influenza Infection5 January 2018
Conditions: Influenza With Pneumonia; Aspergillosis Invasive
Intervention:
Sponsor: Universitaire Ziekenhuizen Leuven
Recruiting -
Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients19 December 2017
Condition: Aspergillosis; Pulmonary, Invasive (Etiology)
Interventions: Drug: SOC +Posaconazole 18 MG/ML (milligram/milliliter); Other: standard of care (SOC)
Sponsors: Universitaire Ziekenhuizen Leuven; Merck Sharp & Dohme Corp.
Recruiting -
Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis22 November 2017
Condition: Invasive Aspergillosis in Patients With Onco-haematological Diseases
Intervention: Diagnostic Test: DNA extraction and detection of Aspergillus fumigatus in serum samples
Sponsors: Assistance Publique – Hôpitaux de Paris; Société ADEMTECH SA
Recruiting -
Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects13 November 2017
Condition: Invasive Aspergillosis
Intervention: Drug: F901318
Sponsors: F2G Ltd.; Covance
Completed -
VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults31 October 2017
Conditions: Invasive Aspergillosis; Invasive Pulmonary Aspergillosis
Interventions: Drug: Investigational Agent: VL-2397; Drug: Standard treatment: Voriconazole, Isavuconazole, or Liposomal amphotericin B
Sponsor: Vical
Terminated